THER: Integrative Web Tool for Tumour Hypoxia Exploration and Research

Yasi Zhang; Huiying Liu; Pengpeng Zhang; BiCheng Ye; Haoxuan Ying; Hong Yang; Jian Zhang; Nan Zhang; Kailai Li; Ting Wei; Aimin Jiang; Anqi Lin; Peng Luo

doi:10.1111/cpr.70053

Cell Proliferation ›› 2025, Vol. 58 ›› Issue (8) : e70053 DOI: 10.1111/cpr.70053

LETTER TO THE EDITOR

THER: Integrative Web Tool for Tumour Hypoxia Exploration and Research

Author information +

¹. Donghai County People's Hospital, Jiangnan University Smart Healthcare Joint Laboratory, Donghai County People's Hospital (Affiliated Kangda College of Nanjing Medical University), Lianyungang, China

². Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

³. Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

⁴. Liver Disease Center of Integrated Traditional Chinese and Western Medicine, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Nanjing, China

⁵. College of Life Science and Technology, Huazhong University of Science and Technology, Hongshan, China

⁶. Department of Urology, Changhai Hospital, Naval Medical University, Second Military Medical University, Shanghai, China

weitingyouyou@qq.com

czjiangaimin@smmu.edu.cn

smulinanqi0206@i.smu.edu.cn

luopeng@smu.edu.cn

Show less

History +

PDF

Cite this article

Download citation ▾

Yasi Zhang, Huiying Liu, Pengpeng Zhang, BiCheng Ye, Haoxuan Ying, Hong Yang, Jian Zhang, Nan Zhang, Kailai Li, Ting Wei, Aimin Jiang, Anqi Lin, Peng Luo. THER: Integrative Web Tool for Tumour Hypoxia Exploration and Research. Cell Proliferation, 2025, 58(8): e70053 DOI:10.1111/cpr.70053

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	M. Höckel and P. Vaupel, “Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects,” Journal of the National Cancer Institute 93 (2001): 266-276, https://doi.org/10.1093/jnci/93.4.266.

[2]	X. Feng, H. Zhang, L. Meng, et al., “Hypoxia-Induced Acetylation of PAK1 Enhances Autophagy and Promotes Brain Tumorigenesis via Phosphorylating ATG5,” Autophagy 17 (2021): 723-742, https://doi.org/10.1080/15548627.2020.1731266.

[3]	V. Bhandari, C. Hoey, L. Y. Liu, et al., “Molecular Landmarks of Tumor Hypoxia Across Cancer Types,” Nature Genetics 51 (2019): 308-318, https://doi.org/10.1038/s41588-018-0318-2.

[4]	S. Hao, F. Li, P. Jiang, and J. Gao, “Effect of Chronic Intermittent Hypoxia-Induced HIF-1α/ATAD2 Expression on Lung Cancer Stemness,” Cellular & Molecular Biology Letters 27 (2022): 44, https://doi.org/10.1186/s11658-022-00345-5.

[5]	M. Höckel, C. Knoop, K. Schlenger, et al., “Intratumoral pO2 Predicts Survival in Advanced Cancer of the Uterine Cervix,” Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 26 (1993): 45-50, https://doi.org/10.1016/0167-8140(93)90025-4.

[6]	A. Fyles, M. Milosevic, D. Hedley, et al., “Tumor Hypoxia has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer,” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20 (2002): 680-687, https://doi.org/10.1200/jco.2002.20.3.680.

[7]	S. Koch, F. Mayer, F. Honecker, M. Schittenhelm, and C. Bokemeyer, “Efficacy of Cytotoxic Agents Used in the Treatment of Testicular Germ Cell Tumours Under Normoxic and Hypoxic Conditions In Vitro,” British Journal of Cancer 89 (2003): 2133-2139, https://doi.org/10.1038/sj.bjc.6601375.

[8]	S. Strese, M. Fryknäs, R. Larsson, and J. Gullbo, “Effects of Hypoxia on Human Cancer Cell Line Chemosensitivity,” BMC Cancer 13 (2013): 331, https://doi.org/10.1186/1471-2407-13-331.

[9]	M. I. Love, W. Huber, and S. Anders, “Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data With DESeq2,” Genome Biology 15 (2014): 550, https://doi.org/10.1186/s13059-014-0550-8.

[10]	L. Gautier, L. Cope, B. M. Bolstad, and R. A. Irizarry, “Affy-Analysis of Affymetrix GeneChip Data at the Probe Level,” Bioinformatics 20 (2004): 307-315, https://doi.org/10.1093/bioinformatics/btg405.

[11]	B. Carvalho, H. Bengtsson, T. P. Speed, and R. A. Irizarry, “Exploration, Normalization, and Genotype Calls of High-Density Oligonucleotide SNP Array Data,” Biostatistics 8 (2007): 485-499, https://doi.org/10.1093/biostatistics/kxl042.

[12]	M. L. Smith, K. A. Baggerly, H. Bengtsson, M. E. Ritchie, and K. D. Hansen, “Illuminaio: An Open Source IDAT Parsing Tool for Illumina Microarrays,” F1000Research 2 (2013): 264, https://doi.org/10.12688/f1000research.2-264.v1.

[13]	M. E. Ritchie, B. Phipson, D. Wu, et al., “Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies,” Nucleic Acids Research 43 (2015): e47, https://doi.org/10.1093/nar/gkv007.

[14]	K. Li, H. Yang, A. Lin, et al., “CPADS: A Web Tool for Comprehensive Pancancer Analysis of Drug Sensitivity,” Briefings in Bioinformatics 25 (2024): bbae237, https://doi.org/10.1093/bib/bbae237.

[15]	J. T. Leek, R. B. Scharpf, H. C. Bravo, et al., “Tackling the Widespread and Critical Impact of Batch Effects in High-Throughput Data,” Nature Reviews. Genetics 11 (2010): 733-739, https://doi.org/10.1038/nrg2825.